Adverse event reports in patients taking psychiatric medication during pregnancy from spontaneous reports in Japan and the United States: an approach using latent class analysis
Open Access
- 12 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Psychiatry
- Vol. 20 (1), 1-14
- https://doi.org/10.1186/s12888-020-02525-z
Abstract
Background Little is known regarding the association between adverse events (AEs) and psychiatric medications administered to pregnant women in clinical trials during the pre-marketing period. This study analyzes reports of AE association with psychiatric medication administrated during pregnancy using post-marketing spontaneous reports of AE from the Japanese Adverse Drug Event Report (JADER) database and Food and Drug Administration Adverse Event Reporting System in the United States (FAERS-US). Methods We summarized AE reports of psychiatric medication administrated during pregnancy by comparing data obtained from JADER and FAERS-US databases with medication patterns determined as classes via latent class analysis. The odds ratios (ORs) of AE reports categorized into system organ classes in which each class was compared with those without psychiatric medications. Results The proportions of AE reports under psychiatric medication in pregnancy among all AE reports were 22.0% and 16.6% in JADER and FAERS-US, respectively. The 10,389 reports of psychiatric medication during pregnancy were classified into 11 classes. The proportion of patients receiving four or more psychiatric drugs in JADER was larger than that in FAERS-US. The maximum number of reports in combinations of AE and medication pattern in JADER was 169, for 'general disorders and administration site conditions' from the class of four or more medications (OR = 9.1), while that in FAERS-US was 1,654, for 'injury, poisoning, and procedural complications' from the class of single psychiatric medication (OR = 2.8). Conclusions The main AE reports and associated AE differed depending on medication patterns in pregnant women taking psychiatric medication. This study may provide a prediction of AEs that are likely to be reported with each medication pattern. Our findings of the association between AE reports and medication patterns could help improve the administration of psychiatric medications during pregnancy, though further research on additional datasets is needed to clarify these results.Funding Information
- Japan Agency for Medical Research and Development (JP18mk0101086., JP18mk0101086.)
This publication has 35 references indexed in Scilit:
- Prevalence of Antidepressant Use during Pregnancy in Denmark, a Nation-Wide Cohort StudyPLOS ONE, 2013
- Neonatal Drug WithdrawalPEDIATRICS, 2012
- Rifampicin Does not Significantly Affect the Expression of Small Heterodimer Partner in Primary Human HepatocytesFrontiers in Pharmacology, 2012
- Drug Interactions at the Human Placenta: What is the Evidence?Frontiers in Pharmacology, 2012
- Psychiatric Disorders in Pregnant and Postpartum Women in the United StatesArchives of General Psychiatry, 2008
- Deciding on the Number of Classes in Latent Class Analysis and Growth Mixture Modeling: A Monte Carlo Simulation StudyStructural Equation Modeling: A Multidisciplinary Journal, 2007
- Increasing use of antidepressants in pregnancyAmerican Journal of Obstetrics and Gynecology, 2007
- Psychotropic Effects of Antiepileptic DrugsEpilepsy Currents, 2005
- Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?CMAJ : Canadian Medical Association Journal, 2005
- Prescription drug use in pregnancyAmerican Journal of Obstetrics and Gynecology, 2004